Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 750

1.

DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patient.

Ruggieri S, Viggiano L, Annese T, Rubolino C, Gerbino A, De Zio R, Corsi P, Tamma R, Ribatti D, Errede M, Operto F, Margari L, Resta N, Di Tommaso S, Rosati J, Trojano M, Nico B.

Stem Cell Res Ther. 2019 Jan 15;10(1):29. doi: 10.1186/s13287-018-1125-5.

PMID:
30646960
2.

STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma.

Tamma R, Ingravallo G, Albano F, Gaudio F, Annese T, Ruggieri S, Lorusso L, Errede M, Maiorano E, Specchia G, Ribatti D.

Transl Oncol. 2019 Jan 6;12(3):545-549. doi: 10.1016/j.tranon.2018.12.008. [Epub ahead of print]

3.

Giulio Gabbiani and the discovery of myofibroblasts.

Ribatti D, Tamma R.

Inflamm Res. 2019 Jan 4. doi: 10.1007/s00011-018-01211-x. [Epub ahead of print]

PMID:
30610292
4.

The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren's Syndrome.

Sisto M, Lorusso L, Ingravallo G, Tamma R, Ribatti D, Lisi S.

Mediators Inflamm. 2018 Nov 26;2018:1965935. doi: 10.1155/2018/1965935. eCollection 2018.

5.

Erythropoietin in tumor angiogenesis.

Annese T, Tamma R, Ruggieri S, Ribatti D.

Exp Cell Res. 2019 Jan 15;374(2):266-273. doi: 10.1016/j.yexcr.2018.12.013. Epub 2018 Dec 18. Review.

PMID:
30576679
6.

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.

Lucarelli G, Rutigliano M, Sallustio F, Ribatti D, Giglio A, Lepore Signorile M, Grossi V, Sanese P, Napoli A, Maiorano E, Bianchi C, Perego RA, Ferro M, Ranieri E, Serino G, Bell LN, Ditonno P, Simone C, Battaglia M.

Aging (Albany NY). 2018 Dec 11;10(12):3957-3985. doi: 10.18632/aging.101685.

7.

Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?

Saltarella I, Frassanito MA, Lamanuzzi A, Brevi A, Leone P, Desantis V, Di Marzo L, Bellone M, Derudas D, Ribatti D, Chiaramonte R, Palano MT, Neri A, Mariggiò MA, Fumarulo R, Dammacco F, Racanelli V, Vacca A, Ria R.

Neoplasia. 2019 Jan;21(1):93-105. doi: 10.1016/j.neo.2018.10.011. Epub 2018 Dec 5.

8.

Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation.

Tamma R, Limongelli L, Maiorano E, Pastore D, Cascardi E, Tempesta A, Carluccio P, Mastropasqua MG, Capodiferro S, Covelli C, Pentenero M, Annese T, Favia G, Specchia G, Ribatti D.

Ann Hematol. 2018 Dec 5. doi: 10.1007/s00277-018-3575-3. [Epub ahead of print]

PMID:
30519712
9.

Hans Selye and his studies on the role of mast cells in calciphylaxis and calcergy.

Ribatti D.

Inflamm Res. 2018 Nov 19. doi: 10.1007/s00011-018-1199-7. [Epub ahead of print]

PMID:
30456595
10.

Interleukins as modulators of angiogenesis and anti-angiogenesis in tumors.

Ribatti D.

Cytokine. 2018 Oct 30. pii: S1043-4666(18)30410-1. doi: 10.1016/j.cyto.2018.10.022. [Epub ahead of print] Review.

PMID:
30389232
11.

Hematopoietic growth factors and tumor angiogenesis.

Ribatti D, Tamma R.

Cancer Lett. 2019 Jan;440-441:47-53. doi: 10.1016/j.canlet.2018.10.008. Epub 2018 Oct 10.

PMID:
30312730
12.

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.

Ponzoni M, Curnis F, Brignole C, Bruno S, Guarnieri D, Sitia L, Marotta R, Sacchi A, Bauckneht M, Buschiazzo A, Rossi A, Di Paolo D, Perri P, Gori A, Sementa AR, Emionite L, Cilli M, Tamma R, Ribatti D, Pompa PP, Marini C, Sambuceti G, Corti A, Pastorino F.

Small. 2018 Nov;14(45):e1802886. doi: 10.1002/smll.201802886. Epub 2018 Oct 7.

PMID:
30294852
13.

Cross talk between natural killer cells and mast cells in tumor angiogenesis.

Ribatti D, Tamma R, Crivellato E.

Inflamm Res. 2019 Jan;68(1):19-23. doi: 10.1007/s00011-018-1181-4. Epub 2018 Aug 21. Review.

PMID:
30132016
14.

Mast cells and primary systemic vasculitides.

Ribatti D, Tamma R, Ruggieri S, Annese T, Marzullo A, Crivellato E.

Microcirculation. 2018 Nov;25(8):e12498. doi: 10.1111/micc.12498. Epub 2018 Sep 12. Review.

PMID:
30120855
15.

Hydrogels for biomedical applications from glycol chitosan and PEG diglycidyl ether exhibit pro-angiogenic and antibacterial activity.

Tripodo G, Trapani A, Rosato A, Di Franco C, Tamma R, Trapani G, Ribatti D, Mandracchia D.

Carbohydr Polym. 2018 Oct 15;198:124-130. doi: 10.1016/j.carbpol.2018.06.061. Epub 2018 Jun 18.

PMID:
30092982
16.

[New frontiers of therapy: bibliotherapy.]

Centonze V, Palmieri VO, Addabbo F, Palmiotti GP, Albano MG, Ribatti D, Portincasa P.

Recenti Prog Med. 2018 Jul-Aug;109(7):384-387. doi: 10.1701/2955.29707. Italian.

PMID:
30087501
17.

The chick embryo chorioallantoic membrane as an in vivo experimental model to study human neuroblastoma.

Ribatti D, Tamma R.

J Cell Physiol. 2018 Jan;234(1):152-157. doi: 10.1002/jcp.26773. Epub 2018 Aug 5. Review.

PMID:
30078179
18.

New Insights in Anti-Angiogenesis in Multiple Myeloma.

Ribatti D, Vacca A.

Int J Mol Sci. 2018 Jul 12;19(7). pii: E2031. doi: 10.3390/ijms19072031. Review.

19.

The dual role of mast cells in tumor fate.

Ribatti D, Tamma R, Crivellato E.

Cancer Lett. 2018 Oct 1;433:252-258. doi: 10.1016/j.canlet.2018.07.005. Epub 2018 Jul 5.

PMID:
29981810
20.

A revisited concept. Tumors: Wounds that do not heal.

Ribatti D, Tamma R.

Crit Rev Oncol Hematol. 2018 Aug;128:65-69. doi: 10.1016/j.critrevonc.2018.05.016. Epub 2018 Jun 6. Review.

PMID:
29958632
21.

Use of the Stromal Vascular Fraction in Intermediate-Deep Acute Burns: A Case With Its Own Control.

Giudice G, Filoni A, Maggio G, Bonamonte D, Maruccia M, Nacchiero E, Ribatti D, Annese T, Vestita M.

J Burn Care Res. 2018 Aug 17;39(5):846-849. doi: 10.1093/jbcr/irx017.

PMID:
29931257
22.
23.

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

Tamma R, Ruggieri S, Annese T, Simone G, Mangia A, Rega S, Zito FA, Nico B, Ribatti D.

Oncotarget. 2018 Apr 27;9(32):22727-22740. doi: 10.18632/oncotarget.25220. eCollection 2018 Apr 27.

24.

The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands.

Sisto M, Lisi S, Ribatti D.

Histochem Cell Biol. 2018 Aug;150(2):133-147. doi: 10.1007/s00418-018-1680-y. Epub 2018 May 23. Review.

PMID:
29789993
25.

Historical overview of lymphangiogenesis.

Ribatti D.

Curr Opin Immunol. 2018 Aug;53:161-166. doi: 10.1016/j.coi.2018.04.027. Epub 2018 May 19.

PMID:
29787938
26.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 Aug;21(3):425-532. doi: 10.1007/s10456-018-9613-x. Review.

27.

VEGFA and VEGFR2 RNAscope determination in gastric cancer.

Tamma R, Annese T, Ruggieri S, Marzullo A, Nico B, Ribatti D.

J Mol Histol. 2018 May 14. doi: 10.1007/s10735-018-9777-0. [Epub ahead of print]

PMID:
29761299
28.

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

Lamanuzzi A, Saltarella I, Desantis V, Frassanito MA, Leone P, Racanelli V, Nico B, Ribatti D, Ditonno P, Prete M, Solimando AG, Dammacco F, Vacca A, Ria R.

Oncotarget. 2018 Apr 17;9(29):20563-20577. doi: 10.18632/oncotarget.25003. eCollection 2018 Apr 17.

29.

[Alzheimer's disease: an actual planetary health emergency.]

Ribatti D.

Recenti Prog Med. 2018 Apr;109(4):249-253. doi: 10.1701/2896.29197. Italian.

PMID:
29689041
30.

Publisher Correction: Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats.

Sjöqvist S, Jungebluth P, Lim ML, Haag JC, Gustafsson Y, Lemon G, Baiguera S, Burguillos MA, Del Gaudio C, Rodríguez AB, Sotnichenko A, Kublickiene K, Ullman H, Kielstein H, Damberg P, Bianco A, Heuchel R, Zhao Y, Ribatti D, Ibarra C, Joseph B, Taylor DA, Macchiarini P.

Nat Commun. 2018 Apr 10;9:16208. doi: 10.1038/ncomms16208.

31.

The Staining of Mast Cells: A Historical Overview.

Ribatti D.

Int Arch Allergy Immunol. 2018;176(1):55-60. doi: 10.1159/000487538. Epub 2018 Mar 29.

32.

Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.

Desantis V, Frassanito MA, Tamma R, Saltarella I, Di Marzo L, Lamanuzzi A, Solimando AG, Ruggieri S, Annese T, Nico B, Vacca A, Ribatti D.

Ann Hematol. 2018 Jul;97(7):1251-1258. doi: 10.1007/s00277-018-3293-x. Epub 2018 Mar 28.

PMID:
29589107
33.

Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study.

Rao L, De Veirman K, Giannico D, Saltarella I, Desantis V, Frassanito MA, Solimando AG, Ribatti D, Prete M, Harstrick A, Fiedler U, De Raeve H, Racanelli V, Vanderkerken K, Vacca A.

Oncotarget. 2018 Jan 30;9(17):13366-13381. doi: 10.18632/oncotarget.24351. eCollection 2018 Mar 2.

34.

A new role of mast cells in arteriogenesis.

Ribatti D.

Microvasc Res. 2018 Jul;118:57-60. doi: 10.1016/j.mvr.2018.02.008. Epub 2018 Mar 5. Review.

PMID:
29501537
35.

<em>Recensione</em><BR> Storia dell'AIDS.

Ribatti D.

Recenti Prog Med. 2018 Feb;109(2):153. doi: 10.1701/2865.28916. Italian. No abstract available.

PMID:
29493647
36.

Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.

Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D.

Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Review.

PMID:
29492715
37.

Natalizumab reduces serum pro-angiogenic activity in MS patients.

Iaffaldano P, Ribatti D, Trojano M.

Neurol Sci. 2018 Apr;39(4):725-731. doi: 10.1007/s10072-018-3266-9. Epub 2018 Feb 13.

PMID:
29441483
38.

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Ferretti E, Di Carlo E, Ognio E, Fraternali-Orcioni G, Corcione A, Belmonte B, Ravetti JL, Tripodo C, Ribatti D, Pistoia V.

Oncoimmunology. 2017 Nov 27;7(3):e1397249. doi: 10.1080/2162402X.2017.1397249. eCollection 2018.

39.

An historical note on the cell theory.

Ribatti D.

Exp Cell Res. 2018 Mar 1;364(1):1-4. doi: 10.1016/j.yexcr.2018.01.038. Epub 2018 Jan 31. Review.

PMID:
29391153
40.

Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.

Gaudio F, Tamma R, Ingravallo G, Perrone T, Laddaga FE, De Candia M, Maiorano E, Ribatti D, Specchia G.

Ann Hematol. 2018 Apr;97(4):663-668. doi: 10.1007/s00277-017-3212-6. Epub 2018 Jan 23.

PMID:
29362889
41.

Reduced myofilament component in primary Sjögren's syndrome salivary gland myoepithelial cells.

Sisto M, Lorusso L, Ingravallo G, Tamma R, Nico B, Ribatti D, Ruggieri S, Lisi S.

J Mol Histol. 2018 Apr;49(2):111-121. doi: 10.1007/s10735-017-9751-2. Epub 2018 Jan 4.

PMID:
29302763
42.

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biologics. 2017 Dec 14;11:123-128. doi: 10.2147/BTT.S143674. eCollection 2017. Review.

43.

The functional anatomy of the cerebrocerebellar circuit: A review and new concepts.

Benagiano V, Rizzi A, Lorusso L, Flace P, Saccia M, Cagiano R, Ribatti D, Roncali L, Ambrosi G.

J Comp Neurol. 2018 Apr 1;526(5):769-789. doi: 10.1002/cne.24361. Epub 2017 Dec 26. Review.

PMID:
29238972
44.

Angiogenesis in adenosquamous cancer of pancreas.

Silvestris N, Danza K, Longo V, Brunetti O, Fucci L, Argentiero A, Calabrese A, Cataldo I, Tamma R, Ribatti D, Tommasi S.

Oncotarget. 2017 Sep 27;8(56):95773-95779. doi: 10.18632/oncotarget.21319. eCollection 2017 Nov 10.

45.

A historical perspective on milestones in multiple myeloma research.

Ribatti D.

Eur J Haematol. 2018 Mar;100(3):221-228. doi: 10.1111/ejh.13003. Epub 2017 Dec 27. Review.

PMID:
29194778
46.

[Reflections on the death of my father.]

Ribatti D.

Recenti Prog Med. 2017 Nov;108(11):481-484. doi: 10.1701/2812.28443. Italian.

PMID:
29149165
47.

Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.

Ronca R, Tamma R, Coltrini D, Ruggieri S, Presta M, Ribatti D.

Oncotarget. 2017 Aug 1;8(47):82583-82592. doi: 10.18632/oncotarget.19773. eCollection 2017 Oct 10.

48.

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?

Puxeddu I, Pratesi F, Ribatti D, Migliorini P.

Mediators Inflamm. 2017;2017:4123694. doi: 10.1155/2017/4123694. Epub 2017 Sep 5. Review.

49.

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biomed Res Int. 2017;2017:5312813. doi: 10.1155/2017/5312813. Epub 2017 Jul 19. Review.

50.

Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.

Cantatore FP, Maruotti N, Corrado A, Ribatti D.

Biomed Res Int. 2017;2017:5345673. doi: 10.1155/2017/5345673. Epub 2017 Jul 16. Review.

Supplemental Content

Loading ...
Support Center